BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 8089302)

  • 1. Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid.
    Wolf P; Fink-Puches R; Cerroni L; Kerl H
    J Am Acad Dermatol; 1994 Oct; 31(4):678-80. PubMed ID: 8089302
    [No Abstract]   [Full Text] [Related]  

  • 2. Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid.
    Ammann R; Hunziker T
    J Am Acad Dermatol; 1995 Sep; 33(3):541. PubMed ID: 7657887
    [No Abstract]   [Full Text] [Related]  

  • 3. Topical photodynamic therapy with 5-aminolevulinate for the treatment of tumor-stage mycosis fungoides: a case report.
    Hasson A; Navarrete-Dechent C; Nicklas C; Sazunic I
    Int J Dermatol; 2013 Dec; 52(12):1535-7. PubMed ID: 24134456
    [No Abstract]   [Full Text] [Related]  

  • 4. Topical 5-aminolaevulinic acid photodynamic therapy for tumour-stage mycosis fungoides.
    Markham T; Sheahan K; Collins P
    Br J Dermatol; 2001 Jun; 144(6):1262-3. PubMed ID: 11422054
    [No Abstract]   [Full Text] [Related]  

  • 5. Mycosis fungoides showing incomplete response to topical 5-aminolaevulinic acid phototherapy.
    Kim EH; Kang HY; Lee ES; Kim YC
    Eur J Dermatol; 2007; 17(4):343-5. PubMed ID: 17540651
    [No Abstract]   [Full Text] [Related]  

  • 6. Topical methyl aminolaevulinate-photodynamic therapy in erosive facial mycosis fungoides.
    Debu A; Girard C; Kluger N; Guillot B; Dereure O
    Br J Dermatol; 2010 Oct; 163(4):884-5. PubMed ID: 20854405
    [No Abstract]   [Full Text] [Related]  

  • 7. Photodynamic therapy with methyl-aminolaevulinic acid for mycosis fungoides.
    Kim ST; Kang DY; Kang JS; Baek JW; Jeon YS; Suh KS
    Acta Derm Venereol; 2012 May; 92(3):264-8. PubMed ID: 22170261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy with methyl aminolaevulinate for cervical and/or facial lesions of folliculotropic mycosis fungoides: interest and limits.
    Debu A; Bessis D; Girard C; Du Thanh A; Guillot B; Dereure O
    Br J Dermatol; 2013 Apr; 168(4):896-8. PubMed ID: 23013351
    [No Abstract]   [Full Text] [Related]  

  • 9. Blue light photodynamic therapy with 5-aminolevulinic acid in refractory mycosis fungoides: A prospective, open-label study.
    Severson KJ; Cumsky HJL; Brumfiel CM; Janeczek MC; Ginos BF; Kosiorek HE; Besch-Stokes J; Patel MH; Rule WG; DiCaudo DJ; Rosenthal AC; Pittelkow MR; Mangold AR
    J Am Acad Dermatol; 2021 Oct; 85(4):969-971. PubMed ID: 33493572
    [No Abstract]   [Full Text] [Related]  

  • 10. [Plaque-phase mycosis fungoides treated with photodynamic therapy: results from 12 patients].
    Fernández-Guarino M; Harto A; Pérez-García B; Montull C; De Las Heras E; Jaén P
    Actas Dermosifiliogr; 2010 Nov; 101(9):785-91. PubMed ID: 21034709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic therapy with methyl-aminolevulinic acid for paucilesional mycosis fungoides: a prospective open study and review of the literature.
    Quéreux G; Brocard A; Saint-Jean M; Peuvrel L; Knol AC; Allix R; Khammari A; Renaut JJ; Dréno B
    J Am Acad Dermatol; 2013 Dec; 69(6):890-7. PubMed ID: 24041738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic therapy of cutaneous lymphoma using 5-aminolevulinic acid topical application.
    Orenstein A; Haik J; Tamir J; Winkler E; Trau H; Malik Z; Kostenich G
    Dermatol Surg; 2000 Aug; 26(8):765-9; discussion 769-70. PubMed ID: 10940064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical 5-aminolevulinic acid photodynamic therapy for the treatment of unilesional mycosis fungoides: a report of two cases and review of the literature.
    Recio ED; Zambrano B; Alonso ML; de Eusebio E; Martín M; Cuevas J; Jaén P
    Int J Dermatol; 2008 Apr; 47(4):410-3. PubMed ID: 18377612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remission of a cutaneous Mycosis fungoides after topical 5-ALA sensitisation and photodynamic therapy in a patient with advanced HIV-infection.
    Paech V; Lorenzen T; Stoehr A; Lange K; Merz H; Meigel WN; Plettenberg A
    Eur J Med Res; 2002 Nov; 7(11):477-9. PubMed ID: 12568975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy as an alternative treatment for mycosis fungoides: a systemic review and meta-analysis.
    Seyed Jafari SM; Cazzaniga S; Hunger RE
    G Ital Dermatol Venereol; 2018 Dec; 153(6):827-832. PubMed ID: 29683282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observation of clinical efficacy of photodynamic therapy in 3 patients with refractory plaque-stage mycosis fungoides.
    Han D; Xue J; Wang T; Liu Y
    Photodiagnosis Photodyn Ther; 2016 Dec; 16():9-11. PubMed ID: 27503781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy as an alternative treatment for relapsed or refractory mycosis fungoides: A systemic review.
    Xue J; Liu C; Liu Y
    Photodiagnosis Photodyn Ther; 2017 Mar; 17():87-91. PubMed ID: 27888162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of unilesional mycosis fungoides with methyl aminolevulinate-photodynamic therapy.
    Hegyi J; Frey T; Arenberger P
    J Eur Acad Dermatol Venereol; 2008 Sep; 22(9):1134-5. PubMed ID: 18266688
    [No Abstract]   [Full Text] [Related]  

  • 19. Photodynamic therapy with intradermal application of 5-aminolevulinic acid successfully improved tumor lesions of mycosis fungoides.
    Kabata Y; Shimomura Y; Matsuo Y; Fujiwara H; Abe R
    Int J Dermatol; 2017 Apr; 56(4):e81-e82. PubMed ID: 28133722
    [No Abstract]   [Full Text] [Related]  

  • 20. Photodynamic therapy with topical 5-aminolevulinic acid for mycosis fungoides: clinical and histological response.
    Edström DW; Porwit A; Ros AM
    Acta Derm Venereol; 2001; 81(3):184-8. PubMed ID: 11558874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.